Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. (CUE) is a healthcare company (biotechnology) based in the United States. The share price is $2.83, down 79.93% on the day, which values the company at $20.56M. Price as of 18 Nov 2026, 12:42 UTC, from Yahoo Finance.

Key facts

Share price
$2.83−79.93% today
Market value
$20.56M
Funk Score
51/100
Against its own history
Well below its usual priceusual price $109.32
200-week average
$46.1594% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Cue Biopharma, Inc. in more detail

CUE trades at -5.9× next year's expected earnings, 0.6× sales. Measured against its own history, the price is 97% below what its usual multiples would imply ($109.32) — well below its usual price. It sits 94% below its 200-week average of $46.15.

Over the last five fiscal years Cue Biopharma, Inc. has compounded revenue 54.2% a year. Its Funk Score is 51 out of 100 (financial strength 4.1, profitability 2.0, growth 9.3, value 5.0, each out of 10).

In its favour: Operating margin is expanding; More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

Cue Biopharma, Inc. (CUE): questions and answers

What is Cue Biopharma, Inc.'s market cap?

Cue Biopharma, Inc. is valued at $20.56M at a share price of $2.83.

Is CUE overvalued or undervalued?

Against its own history, CUE is well below its usual price: the price is 97% below the $109.32 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is CUE above its 200-week moving average?

No. CUE is 93.9% below its 200-week average of $46.15. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Cue Biopharma, Inc. growing?

Over the last five fiscal years Cue Biopharma, Inc.'s revenue grew 54.2% a year.

Does CUE pay a dividend?

Cue Biopharma, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Cue Biopharma, Inc. (CUE) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CUE

Underlying data: Yahoo Finance; company filings with the SEC.